About
Activities

Please donate

Please support us
with your donation
Donate here

Member Area
Search
Member Login

Some areas of this website are accessible to registered members only.


If you have no account yet, please click on "Register". If you have forgotten your password, please click on "Forgot login?".

Members Online
None
You are here: Home Virtual Education Program Jerry Radich - Transplantation for CML in 2011: Who, why, when?

Transplantation for CML in 2011: Who, why, when?

Jerry Radich, Fred Hutchinson Cancer Research Center, Seattle, USA

Please wait some seconds before the educational presentation will start below. You can also click on the slides to jump to certain sections of the presentation. Please share your feedback below, and see the other Virtual Education Program modules.

Issues covered

  • The role of transplantation in 2011
  • Who should be transplanted
  • When they should be transplanted
  • Why they should be transplanted

Has this been helpful? Please provide your comments here:

Facteur de variabilité de la réponse au ITK</li>
              <li>Les trois grand mécanismes de résistance</li>
              <li>La réponse au traitement</li>
              <li>Autres inhibiteurs de tyrosine kinase: le Nilotinib et le Dasatinib

 5000 Characters left

Antispam Refresh image Case sensitive

© iCMLf International Chronic Myeloid Leukemia Foundation